首页 > 最新文献

Enfermedades infecciosas y microbiologia clinica最新文献

英文 中文
Ecografía clínica: presente y futuro en enfermedades infecciosas 临床超声:传染病的现状与未来
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2024.01.007
{"title":"Ecografía clínica: presente y futuro en enfermedades infecciosas","authors":"","doi":"10.1016/j.eimc.2024.01.007","DOIUrl":"10.1016/j.eimc.2024.01.007","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 394-395"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140312925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing pneumococcal bacteraemia diagnosis: A comparative assessment of culture-independent assays (MALDI–TOF–MS Sepsityper® module and a lateral flow inmunochromatography test) 加强肺炎球菌菌血症诊断:独立于培养的检测方法(MALDI-TOF-MS Sepsityper® 模块和侧流免疫层析检测)的比较评估
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2024.02.001

Introduction

Pneumococcal bacteraemia is a major contributor to global morbidity and mortality. Traditional culture-based methods lack sensitivity and are time-consuming. This study aimed to assess the effectiveness of two culture-independent assays, the MALDI–TOF–MS Sepsityper® module and the lateral flow inmunochromatography test (LFICT) with the Standard F® Streptococcus pneumoniae, directly from positive blood culture (BC) bottles.

Methods

A prospective study was conducted from December 2021 to July 2022. For all BC positives for S. pneumoniae a double centrifugation protocol was implemented. The resulting pellet was subsequently processed using both techniques.

Results

The LFICT showed exceptional performance with 100% sensitivity and specificity, outperforming the MALDI–TOF–MS Sepsityper® module, which achieved 85.2% sensitivity and 100% specificity. Nevertheless, the combination of these assays offers a robust and comprehensive approach to diagnosis.

Conclusions

The simultaneous use of both techniques offers a promising alternative that can be integrated into routine practices directly from BC samples.

肺炎球菌菌血症是导致全球发病率和死亡率的一个主要因素。传统的培养法缺乏灵敏度且耗时。本研究旨在评估两种独立于培养的检测方法的有效性,即直接从阳性血培养物(BC)瓶中检测MALDI-TOF-MS Sepsityper®模块和使用标准F®的侧流免疫层析检测(LFICT)。2021 年 12 月至 2022 年 7 月期间进行了一项前瞻性研究。对所有 BC 阳性样本都采用了双重离心方案。随后使用这两种技术对得到的颗粒进行处理。LFICT 显示出卓越的性能,灵敏度和特异性均达到 100%,优于 MALDI-TOF-MS Sepsityper® 模块,后者的灵敏度为 85.2%,特异性为 100%。尽管如此,将这些检测方法结合起来可提供一种可靠而全面的诊断方法。同时使用这两种技术提供了一种很有前景的替代方法,可以直接从 BC 样品中整合到常规实践中。
{"title":"Enhancing pneumococcal bacteraemia diagnosis: A comparative assessment of culture-independent assays (MALDI–TOF–MS Sepsityper® module and a lateral flow inmunochromatography test)","authors":"","doi":"10.1016/j.eimc.2024.02.001","DOIUrl":"10.1016/j.eimc.2024.02.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Pneumococcal bacteraemia is a major contributor to global morbidity and mortality. Traditional culture-based methods lack sensitivity and are time-consuming. This study aimed to assess the effectiveness of two culture-independent assays, the MALDI–TOF–MS Sepsityper® module and the lateral flow inmunochromatography test (LFICT) with the Standard F® <em>Streptococcus pneumoniae</em>, directly from positive blood culture (BC) bottles.</p></div><div><h3>Methods</h3><p>A prospective study was conducted from December 2021 to July 2022. For all BC positives for <span><span>S. pneumoniae</span></span> a double centrifugation protocol was implemented. The resulting pellet was subsequently processed using both techniques.</p></div><div><h3>Results</h3><p>The LFICT showed exceptional performance with 100% sensitivity and specificity, outperforming the MALDI–TOF–MS Sepsityper® module, which achieved 85.2% sensitivity and 100% specificity. Nevertheless, the combination of these assays offers a robust and comprehensive approach to diagnosis.</p></div><div><h3>Conclusions</h3><p>The simultaneous use of both techniques offers a promising alternative that can be integrated into routine practices directly from BC samples.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 377-379"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140126947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparación de medios de cultivo para la detección de Legionella spp. en muestras de agua sanitaria: adaptación a la norma ISO 11731:2017 用于检测卫生水样中军团菌属的培养基比较:ISO 11731:2017 适应版
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2024.03.013

Introduction

Water sample culturing is the reference method to detect Legionella spp. in sanitary facilities. Until 2017, UNE-EN ISO 11731 only included the GVPC medium, which inhibits interfering microbiota but hinders the growth of Legionella spp. To improve its recovery, the new standard incorporates the BCYE medium into the working protocol.

Methods

We inoculated 1,306 sanitary water samples onto BCYE and GVPC according to an accredited internal procedure. We compared the number of cfu/L of Legionella spp. detected in both media.

Results

The median in BCYE was 2,000 cfu/L higher than in GVPC (p = 0.000). In the presence of high amounts of interfering microbiota, both media were similar; in the absence or low interfering microbiota BCYE was four times more sensitive than GVPC (p = 0.000).

Conclusion

Including BCYE in the analysis of sanitary water significantly improves the recovery of Legionella spp. in low contaminated samples.

引言水样培养是检测卫生设施中军团菌属的参考方法。在 2017 年之前,UNE-EN ISO 11731 仅包括 GVPC 培养基,该培养基可抑制干扰微生物群,但阻碍军团菌的生长。为了提高其回收率,新标准将 BCYE 培养基纳入了工作方案。结果 BCYE 中的中位数比 GVPC 中高 2000 cfu/L(p = 0.000)。在存在大量干扰微生物群的情况下,两种培养基的灵敏度相似;在没有干扰微生物群或干扰微生物群较少的情况下,BCYE 的灵敏度是 GVPC 的四倍(p = 0.000)。
{"title":"Comparación de medios de cultivo para la detección de Legionella spp. en muestras de agua sanitaria: adaptación a la norma ISO 11731:2017","authors":"","doi":"10.1016/j.eimc.2024.03.013","DOIUrl":"10.1016/j.eimc.2024.03.013","url":null,"abstract":"<div><h3>Introduction</h3><p>Water sample culturing is the reference method to detect <em>Legionella</em> spp. in sanitary facilities. Until 2017, UNE-EN ISO 11731 only included the GVPC medium, which inhibits interfering microbiota but hinders the growth of <em>Legionella</em> spp. To improve its recovery, the new standard incorporates the BCYE medium into the working protocol.</p></div><div><h3>Methods</h3><p>We inoculated 1,306 sanitary water samples onto BCYE and GVPC according to an accredited internal procedure. We compared the number of cfu/L of <em>Legionella</em> spp. detected in both media.</p></div><div><h3>Results</h3><p>The median in BCYE was 2,000<!--> <!-->cfu/L higher than in GVPC (p<!--> <!-->=<!--> <!-->0.000). In the presence of high amounts of interfering microbiota, both media were similar; in the absence or low interfering microbiota BCYE was four times more sensitive than GVPC (p<!--> <!-->=<!--> <!-->0.000).</p></div><div><h3>Conclusion</h3><p>Including BCYE in the analysis of sanitary water significantly improves the recovery of <em>Legionella</em> spp. in low contaminated samples.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 373-376"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140768978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intertrigo inguinal: ¿infeccioso o inflamatorio? 腹股沟间肌:是损伤性还是炎症性?
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2023.12.007
{"title":"Intertrigo inguinal: ¿infeccioso o inflamatorio?","authors":"","doi":"10.1016/j.eimc.2023.12.007","DOIUrl":"10.1016/j.eimc.2023.12.007","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 388-389"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139095754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resumen ejecutivo de las Guías Española de Diagnóstico y Manejo de Enfermedades Febriles Importadas de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI), el Grupo de Patología Importada de la Sociedad Española de Enfermedades Infecciosas y microbiología clínica (GEPI-SEIMC), la Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES) 西班牙热带医学和国际健康学会 (SEMTSI)、西班牙传染病和临床微生物学学会进口病理学小组 (GEPI-SEIMC)、西班牙家庭和社区医学学会 (SEMFYC)、西班牙初级保健医生学会 (SEMERGEN) 和西班牙急诊医学学会 (SEMES) 制定的《西班牙进口发热疾病诊断和管理指南》执行摘要。
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2024.05.002

The Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Primary Care Physicians (SEMERGEN) and the Spanish Society of Family and Community Medicine (SEMFYC) have elaborated a consensus statement on the diagnosis and management of patients with imported febrile illnesses.

Twenty authors with different backgrounds and representing different healthcare perspectives (ambulatory primary care, travel and tropical medicine specialists, emergency medicine, hospital care, microbiology and parasitology and public health), identified 39 relevant questions, which were organized in 7 thematic blocks. After a systematic review of the literature and a thoughtful discussion, the authors elaborated 125 recommendations, as well as several tables and figures to be used as a consulting tool. The present executive summary shows a selection of some of the most relevant questions and recommendations included in the guidelines.

西班牙热带医学和国际健康学会 (SEMTSI)、西班牙传染病和临床微生物学会 (SEIMC)、西班牙急诊医学会 (SEMES)、西班牙初级保健医生学会 (SEMERGEN) 以及西班牙家庭和社区医学会 (SEMFYC) 就输入性发热疾病患者的诊断和管理达成了共识声明。
{"title":"Resumen ejecutivo de las Guías Española de Diagnóstico y Manejo de Enfermedades Febriles Importadas de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI), el Grupo de Patología Importada de la Sociedad Española de Enfermedades Infecciosas y microbiología clínica (GEPI-SEIMC), la Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES)","authors":"","doi":"10.1016/j.eimc.2024.05.002","DOIUrl":"10.1016/j.eimc.2024.05.002","url":null,"abstract":"<div><p>The Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Primary Care Physicians (SEMERGEN) and the Spanish Society of Family and Community Medicine (SEMFYC) have elaborated a consensus statement on the diagnosis and management of patients with imported febrile illnesses.</p><p>Twenty authors with different backgrounds and representing different healthcare perspectives (ambulatory primary care, travel and tropical medicine specialists, emergency medicine, hospital care, microbiology and parasitology and public health), identified 39 relevant questions, which were organized in 7 thematic blocks. After a systematic review of the literature and a thoughtful discussion, the authors elaborated 125 recommendations, as well as several tables and figures to be used as a consulting tool. The present executive summary shows a selection of some of the most relevant questions and recommendations included in the guidelines.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 380-385"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0213005X24002489/pdfft?md5=fbe6e606c7bc1604d760adfc33bfd98f&pid=1-s2.0-S0213005X24002489-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141547251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug burden index in people living with HIV over 50 years of age in a real clinical practice cohort 真实临床实践队列中 50 岁以上艾滋病毒感染者的药物负担指数
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2023.04.010

Objectives

To determine DBI and its relationship with polypharmacy and pharmacotherapeutic complexity (PC) in a cohort of PLWH over 50 years of age at follow-up of pharmacotherapy in a tertiary hospital.

Methods

Observational and retrospective study that included PLWH in active antiretroviral treatment over 50 years of age who have been followed up in outpatient pharmacy services. Pharmacotherapeutic complexity was estimated through Medication Regimen Complexity Index (MRCI). Collected variables included comorbidities, current prescriptions and its classification according to anticholinergic and sedative activity and associated risk of falls.

Results

Studied population included 251 patients (85.7% men; median age: 58 years, interquartile range: 54–61). There was a high prevalence of high DBI scores (49.2%). High DBI was significantly correlated with a high PC, polypharmacy, psychiatric comorbidity and substances abuse (p < 0.05). Among sedative drugs, the most prescribed were anxiolytic drugs (N05B) (n = 85), antidepressant drugs (N06A) (n = 41) and antiepileptic drugs (N03A) (n = 29). For anticholinergic drugs, alpha-adrenergic antagonist drugs (G04C) were the most prescribed (n = 18). Most frequent drugs associated with risk of falls were anxiolytics (N05B) (n = 85), angiotensin-converting enzyme inhibitors (C09A) (n = 61) and antidepressants (N06A) (n = 41).

Conclusion

The DBI score in older PLWH is high and it is related to PC, polypharmacy, mental diseases and substance abuse as is the prevalence of fall-related drugs. Control of these parameters as well as the reduction of the sedative and anticholinergic load should be included in the lines of work in the pharmaceutical care of people living with HIV+.

方法观察性和回顾性研究纳入了在门诊药房接受随访的 50 岁以上接受积极抗逆转录病毒治疗的 PLWH。通过用药方案复杂性指数(MRCI)估算药物治疗的复杂性。收集的变量包括合并症、当前处方及其根据抗胆碱能药物和镇静剂活性进行的分类以及相关的跌倒风险。高 DBI 评分的发生率很高(49.2%)。高 DBI 与高 PC、多重用药、精神疾病合并症和药物滥用有明显相关性(p < 0.05)。在镇静药中,处方最多的是抗焦虑药(N05B)(85 人)、抗抑郁药(N06A)(41 人)和抗癫痫药(N03A)(29 人)。在抗胆碱能药物中,α-肾上腺素能拮抗剂(G04C)是处方量最大的药物(18 人)。与跌倒风险相关的最常见药物是抗焦虑药(N05B)(n = 85)、血管紧张素转换酶抑制剂(C09A)(n = 61)和抗抑郁药(N06A)(n = 41)。控制这些参数以及减少镇静剂和抗胆碱能药物的用量应纳入艾滋病毒感染者药物治疗的工作范围。
{"title":"Drug burden index in people living with HIV over 50 years of age in a real clinical practice cohort","authors":"","doi":"10.1016/j.eimc.2023.04.010","DOIUrl":"10.1016/j.eimc.2023.04.010","url":null,"abstract":"<div><h3>Objectives</h3><p>To determine DBI and its relationship with polypharmacy<span> and pharmacotherapeutic complexity (PC) in a cohort of PLWH over 50 years of age at follow-up of pharmacotherapy in a tertiary hospital.</span></p></div><div><h3>Methods</h3><p>Observational and retrospective study that included PLWH in active antiretroviral treatment over 50 years of age who have been followed up in outpatient pharmacy services. Pharmacotherapeutic complexity was estimated through Medication Regimen Complexity Index (MRCI). Collected variables included comorbidities, current prescriptions and its classification according to anticholinergic and sedative activity and associated risk of falls.</p></div><div><h3>Results</h3><p>Studied population included 251 patients (85.7% men; median age: 58 years, interquartile range: 54–61). There was a high prevalence of high DBI scores (49.2%). High DBI was significantly correlated with a high PC, polypharmacy, psychiatric comorbidity and substances abuse (<em>p</em> <!-->&lt;<!--> <!-->0.05). Among sedative drugs, the most prescribed were anxiolytic drugs (N05B) (<em>n</em> <!-->=<!--> <!-->85), antidepressant drugs (N06A) (<em>n</em> <!-->=<!--> <span>41) and antiepileptic drugs (N03A) (</span><em>n</em> <!-->=<!--> <!-->29). For anticholinergic drugs, alpha-adrenergic antagonist drugs (G04C) were the most prescribed (<em>n</em> <!-->=<!--> <!-->18). Most frequent drugs associated with risk of falls were anxiolytics (N05B) (<em>n</em> <!-->=<!--> <!-->85), angiotensin-converting enzyme inhibitors (C09A) (<em>n</em> <!-->=<!--> <!-->61) and antidepressants (N06A) (<em>n</em> <!-->=<!--> <!-->41).</p></div><div><h3>Conclusion</h3><p>The DBI score in older PLWH is high and it is related to PC, polypharmacy, mental diseases and substance abuse as is the prevalence of fall-related drugs. Control of these parameters as well as the reduction of the sedative and anticholinergic load should be included in the lines of work in the pharmaceutical care of people living with HIV+.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 347-353"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134903980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tendencia en la vacunación en personas con infección por VIH participantes en la Encuesta Hospitalaria de pacientes con VIH, 2006-2021 2006-2021 年参与艾滋病医院住院病人调查的艾滋病毒感染者接种疫苗的趋势
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2023.06.002

Objective

To assess the trend in hepatitis A, hepatitis B, pneumococcal, tetanus and seasonal influenza vaccination in people with HIV infection and to analyse associated factors.

Methods

The hospital survey of patients with HIV, an annual cross-sectional study conducted on a fixed day (2006-2021), was used. Inpatients and outpatients were included. Trends in vaccination and associated factors were analysed using logistic regression.

Results

A total of 8643 participants were included. Vaccination rates increased to 65.3% for hepatitis A, 83.7% for hepatitis B, 49.3% for tetanus, 68.9% for pneumococcal and 74.5% for seasonal influenza in 2021. Factors positively associated with vaccination were older age for pneumococcal and influenza vaccination; higher educational level for hepatitis A and tetanus; living in a closed institutions or prison for tetanus, pneumococcal and influenza; and having acquired HIV through sex between men for hepatitis A, hepatitis B and pneumococcal. In addition, being on antiretroviral treatment and having a high CD4 count were positively associated with vaccination for all these diseases. Factors inversely associated with vaccination were being older (hepatitis A, hepatitis B and tetanus), being an immigrant (tetanus and seasonal influenza) and being an injection drug user/ex-user for hepatitis A and hepatitis B.

Conclusions

Vaccination in people with HIV has increased in the study period. The results are in line with the recommendations in this population, although there is still room to reach the established vaccination indicators.

目的 评估艾滋病病毒感染者接种甲型肝炎、乙型肝炎、肺炎球菌、破伤风和季节性流感疫苗的趋势,并分析相关因素。 方法 采用医院对艾滋病病毒感染者的调查,这是一项在固定日期进行的年度横断面研究(2006-2021 年)。调查对象包括住院病人和门诊病人。结果 共纳入 8643 名参与者。2021 年,甲肝疫苗接种率增至 65.3%,乙肝疫苗接种率增至 83.7%,破伤风疫苗接种率增至 49.3%,肺炎球菌疫苗接种率增至 68.9%,季节性流感疫苗接种率增至 74.5%。与接种疫苗呈正相关的因素有:接种肺炎球菌疫苗和流感疫苗的年龄较大;接种甲型肝炎疫苗和破伤风疫苗的受教育程度较高;接种破伤风疫苗、肺炎球菌疫苗和流感疫苗的人居住在封闭的机构或监狱中;接种甲型肝炎疫苗、乙型肝炎疫苗和肺炎球菌疫苗的人通过男男性行为感染了艾滋病毒。此外,正在接受抗逆转录病毒治疗和 CD4 细胞计数高也与所有这些疾病的疫苗接种呈正相关。与接种疫苗成反比的因素包括年龄较大(甲型肝炎、乙型肝炎和破伤风)、移民(破伤风和季节性流感)以及甲型肝炎和乙型肝炎注射毒品使用者/前使用者。研究结果符合针对该人群的建议,但仍有余地达到既定的疫苗接种指标。
{"title":"Tendencia en la vacunación en personas con infección por VIH participantes en la Encuesta Hospitalaria de pacientes con VIH, 2006-2021","authors":"","doi":"10.1016/j.eimc.2023.06.002","DOIUrl":"10.1016/j.eimc.2023.06.002","url":null,"abstract":"<div><h3>Objective</h3><p>To assess the trend in hepatitis A, hepatitis B, pneumococcal, tetanus and seasonal influenza vaccination in people with HIV infection and to analyse associated factors.</p></div><div><h3>Methods</h3><p>The hospital survey of patients with HIV, an annual cross-sectional study conducted on a fixed day (2006-2021), was used. Inpatients and outpatients were included. Trends in vaccination and associated factors were analysed using logistic regression.</p></div><div><h3>Results</h3><p>A total of 8643 participants were included. Vaccination rates increased to 65.3% for hepatitis A, 83.7% for hepatitis B, 49.3% for tetanus, 68.9% for pneumococcal and 74.5% for seasonal influenza in 2021. Factors positively associated with vaccination were older age for pneumococcal and influenza vaccination; higher educational level for hepatitis A and tetanus; living in a closed institutions or prison for tetanus, pneumococcal and influenza; and having acquired HIV through sex between men for hepatitis A, hepatitis B and pneumococcal. In addition, being on antiretroviral treatment and having a high CD4 count were positively associated with vaccination for all these diseases. Factors inversely associated with vaccination were being older (hepatitis A, hepatitis B and tetanus), being an immigrant (tetanus and seasonal influenza) and being an injection drug user/ex-user for hepatitis A and hepatitis B.</p></div><div><h3>Conclusions</h3><p>Vaccination in people with HIV has increased in the study period. The results are in line with the recommendations in this population, although there is still room to reach the established vaccination indicators.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 339-346"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128446274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Desenlace inesperado de amigdalitis pultácea en persona joven sin comorbilidad 无并发症的年轻人患扁桃体炎的意外结果
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2023.12.006
{"title":"Desenlace inesperado de amigdalitis pultácea en persona joven sin comorbilidad","authors":"","doi":"10.1016/j.eimc.2023.12.006","DOIUrl":"10.1016/j.eimc.2023.12.006","url":null,"abstract":"","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 386-387"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139460211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto de la inmunización con nirsevimab en las infecciones por VRS atendidas en urgencias pediátricas: primeros resultados en un hospital terciario de Madrid nirsevimab 免疫接种对儿科急诊室 RSV 感染的影响:马德里一家三级医院的初步结果。
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2024.04.010

Introduction

Human respiratory syncytial virus (RSV) is the most commonly identified virus associated with lower respiratory tract infections. The monoclonal antibody nirsevimab immunization campaign began in our country in October 2023.

Methods

This study was conducted in the Pediatric Emergency Department (PED) of a tertiary care center in Madrid, Spain. The aim was to compare PED visits of patients eligible for immunization with nirsevimab who attended between weeks 40 and 52 of 2022 and 2023 and who had a confirmed diagnosis of RSV infection.

Results

During the study period, 264 out of 765 patients with confirmed RSV infection who attended the PED were eligible for immunization with nirsevimab and were selected for our analysis. The PED attendance was 80.3% in 2022 and 19.7% in 2023. The number of RSV-positive cases increased from week 42 in both analyzed periods, with a peak of maximum incidence between weeks 46 and 48. In 2022, the morphology of the case curve in the group of children eligible for immunization was similar to the overall curve. However, in 2023, we did not observe a similar increase in cases among patients eligible for immunization.

Conclusion

Immunization with nirsevimab during the 2023 RSV epidemic season had a beneficial effect, reducing the number of PED consultations for RSV infection.

导言人类呼吸道合胞病毒(RSV)是与下呼吸道感染相关的最常见病毒。本研究在西班牙马德里一家三级医疗中心的儿科急诊科(PED)进行。目的是比较 2022 年第 40 周至 2023 年第 52 周期间符合接种 nirsevimab 免疫接种条件且确诊感染 RSV 的患者在 PED 就诊的情况。结果在研究期间,765 名确诊感染 RSV 的患者中有 264 名在 PED 就诊,符合接种 nirsevimab 免疫接种条件,并被选中进行分析。2022年和2023年的PED就诊率分别为80.3%和19.7%。在两个分析期间,RSV 阳性病例的数量从第 42 周开始增加,在第 46 周和第 48 周之间达到最高峰。2022 年,符合免疫条件的儿童群体的病例曲线形态与总体曲线相似。结论在2023年RSV流行季节使用尼舍单抗免疫接种产生了有益的效果,减少了因RSV感染而到PED就诊的人数。
{"title":"Impacto de la inmunización con nirsevimab en las infecciones por VRS atendidas en urgencias pediátricas: primeros resultados en un hospital terciario de Madrid","authors":"","doi":"10.1016/j.eimc.2024.04.010","DOIUrl":"10.1016/j.eimc.2024.04.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Human respiratory syncytial virus (RSV) is the most commonly identified virus associated with lower respiratory tract infections. The monoclonal antibody nirsevimab immunization campaign began in our country in October 2023.</p></div><div><h3>Methods</h3><p>This study was conducted in the Pediatric Emergency Department (PED) of a tertiary care center in Madrid, Spain. The aim was to compare PED visits of patients eligible for immunization with nirsevimab who attended between weeks 40 and 52 of 2022 and 2023 and who had a confirmed diagnosis of RSV infection.</p></div><div><h3>Results</h3><p>During the study period, 264 out of 765 patients with confirmed RSV infection who attended the PED were eligible for immunization with nirsevimab and were selected for our analysis. The PED attendance was 80.3% in 2022 and 19.7% in 2023. The number of RSV-positive cases increased from week 42 in both analyzed periods, with a peak of maximum incidence between weeks 46 and 48. In 2022, the morphology of the case curve in the group of children eligible for immunization was similar to the overall curve. However, in 2023, we did not observe a similar increase in cases among patients eligible for immunization.</p></div><div><h3>Conclusion</h3><p>Immunization with nirsevimab during the 2023 RSV epidemic season had a beneficial effect, reducing the number of PED consultations for RSV infection.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 367-372"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141407589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consideraciones sobre la aplicación del plan formativo de Microbiología y Parasitología clínica en los hospitales de España: una encuesta nacional 西班牙医院实施临床微生物学和寄生虫学培训计划的考虑因素:全国调查
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-01 DOI: 10.1016/j.eimc.2023.06.006

Introduction

The specialty of Microbiology and Parasitology is a four-year multidisciplinary training with a central role in the diagnosis and epidemiological surveillance of infectious diseases.

The aim of this study is to analyze the degree of implementation of the official program and the degree of satisfaction of residents with their training.

Methods

We conducted an online survey distributed in eight sections to which active residents of the Specialty of Clinical Microbiology and Parasitology had access.

Results

A total of 69 responses were received, with a predominance of residents from the regions of Madrid (43.5%) and of FIR admission route (55%).

The areas in which the residents feel best prepared correspond to systematic bacteriology, antimicrobials and clinical aspects of microbiology. The areas with the worst preparation, on the other hand, are mycology, parasitology and microbiological emergencies.

There are significant differences between the clinical rotation time for residents with MIR access pathway with respect to residents with other degrees.

Respondents perceive a high degree of responsibility and a medium agreement with the quality of teaching. Attendance at clinical sessions and external rotations is frequent.

Research activity is perceived as complicated, both at the level of doctoral studies and with respect to entering research lines and the publication of scientific results.

Conclusion

Some points of improvement of the training itinerary have been identified that need to be reinforced. Likewise, it would be interesting to seek a better balance between care, teaching and research activities.

引言 微生物学和寄生虫学专业是一个为期四年的多学科培训专业,在传染病的诊断和流行病学监测方面发挥着核心作用。本研究旨在分析官方计划的实施程度以及住院医师对其培训的满意度。结果 共收到 69 份回复,其中来自马德里地区(43.5%)和 FIR 入院途径(55%)的居民占多数。居民认为准备最充分的领域是系统细菌学、抗菌药物和微生物学的临床方面。另一方面,准备最不充分的领域是真菌学、寄生虫学和微生物急症。与拥有其他学位的住院医师相比,拥有 MIR 入学途径的住院医师的临床轮转时间存在显著差异。研究活动被认为是复杂的,无论是在博士学习阶段,还是在进入研究领域和发表科研成果方面。同样,在护理、教学和研究活动之间寻求更好的平衡也很有意义。
{"title":"Consideraciones sobre la aplicación del plan formativo de Microbiología y Parasitología clínica en los hospitales de España: una encuesta nacional","authors":"","doi":"10.1016/j.eimc.2023.06.006","DOIUrl":"10.1016/j.eimc.2023.06.006","url":null,"abstract":"<div><h3>Introduction</h3><p>The specialty of Microbiology and Parasitology is a four-year multidisciplinary training with a central role in the diagnosis and epidemiological surveillance of infectious diseases.</p><p>The aim of this study is to analyze the degree of implementation of the official program and the degree of satisfaction of residents with their training.</p></div><div><h3>Methods</h3><p>We conducted an online survey distributed in eight sections to which active residents of the Specialty of Clinical Microbiology and Parasitology had access.</p></div><div><h3>Results</h3><p>A total of 69 responses were received, with a predominance of residents from the regions of Madrid (43.5%) and of FIR admission route (55%).</p><p>The areas in which the residents feel best prepared correspond to systematic bacteriology, antimicrobials and clinical aspects of microbiology. The areas with the worst preparation, on the other hand, are mycology, parasitology and microbiological emergencies.</p><p>There are significant differences between the clinical rotation time for residents with MIR access pathway with respect to residents with other degrees.</p><p>Respondents perceive a high degree of responsibility and a medium agreement with the quality of teaching. Attendance at clinical sessions and external rotations is frequent.</p><p>Research activity is perceived as complicated, both at the level of doctoral studies and with respect to entering research lines and the publication of scientific results.</p></div><div><h3>Conclusion</h3><p>Some points of improvement of the training itinerary have been identified that need to be reinforced. Likewise, it would be interesting to seek a better balance between care, teaching and research activities.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 7","pages":"Pages 361-366"},"PeriodicalIF":2.6,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121166813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Enfermedades infecciosas y microbiologia clinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1